{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:10:26Z","timestamp":1791198626611,"version":"4.1.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["30770718"],"award-info":[{"award-number":["30770718"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"crossref","award":["KSCX2-2-03"],"award-info":[{"award-number":["KSCX2-2-03"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"crossref","award":["KSCX2-EW-J-8"],"award-info":[{"award-number":["KSCX2-EW-J-8"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.bbi.2011.01.011","type":"journal-article","created":{"date-parts":[[2011,1,28]],"date-time":"2011-01-28T04:40:36Z","timestamp":1296189636000},"page":"706-714","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Chronic blockade of glucocorticoid receptors by RU486 enhances lipopolysaccharide-induced depressive-like behaviour and cytokine production in rats"],"prefix":"10.1016","volume":"25","author":[{"given":"Donglin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueying","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2011.01.011_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/joe.0.1600001","article-title":"The role of corticotropin-releasing factor in depression and anxiety disorders","volume":"160","author":"Arborelius","year":"1999","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.bbi.2011.01.011_b0010","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1006\/brbi.1995.1013","article-title":"Pyrogens specifically disrupt the acquisition of a task involving cognitive processing in the rat","volume":"9","author":"Aubert","year":"1995","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2011.01.011_b0015","first-page":"25","article-title":"Regulation of corticosteroid receptor gene expression in depression and antidepressant action","volume":"24","author":"Barden","year":"1999","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.bbi.2011.01.011_b0020","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1139\/jpn.0421","article-title":"Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression","volume":"29","author":"Barden","year":"2004","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.bbi.2011.01.011_b0025","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0165-1781(01)00315-8","article-title":"Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms","volume":"105","author":"Bonaccorso","year":"2001","journal-title":"Psychiat. Res."},{"key":"10.1016\/j.bbi.2011.01.011_b0030","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.7326\/0003-4819-119-12-199312150-00007","article-title":"Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates","volume":"119","author":"Boumpas","year":"1993","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bbi.2011.01.011_b0035","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1073\/pnas.0406458102","article-title":"Acquired deficit of forebrain glucocorticoid receptor produces depression-like changes in adrenal axis regulation and behavior","volume":"102","author":"Boyle","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbi.2011.01.011_b0040","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0306-4530(02)00051-3","article-title":"Characterization and functional significance of glucocorticoid receptors in patients with major depression: modulation by antidepressant treatment","volume":"28","author":"Calfa","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bbi.2011.01.011_b0045","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1152\/japplphysiol.00371.2003","article-title":"Circulating cytokines and endotoxin are not necessary for the activation of the sickness or corticosterone response produced by peripheral E. coli challenge","volume":"95","author":"Campisi","year":"2003","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.bbi.2011.01.011_b0050","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0893-133X(01)00407-9","article-title":"Neurobehavioural effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions","volume":"26","author":"Capuron","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbi.2011.01.011_b0055","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1200\/JCO.2000.18.10.2143","article-title":"Early depressive symptoms in cancer patients receiving interleukin 2 and\/or interferon alfa-2b therapy","volume":"18","author":"Capuron","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbi.2011.01.011_b0060","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0306-4530(01)00030-0","article-title":"Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy","volume":"26","author":"Capuron","year":"2001","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bbi.2011.01.011_b0065","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/sj.mp.4000995","article-title":"Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy","volume":"7","author":"Capuron","year":"2002","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.bbi.2011.01.011_b0070","first-page":"348","article-title":"Adaptation of the tail suspension test to the rat","volume":"17","author":"Chermat","year":"1986","journal-title":"J. Pharmacol."},{"key":"10.1016\/j.bbi.2011.01.011_b0075","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.brainresrev.2007.04.008","article-title":"Glucocorticoid receptor transgenic mice as models for depression","volume":"57","author":"Chourbaji","year":"2008","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.bbi.2011.01.011_b0080","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1056\/NEJM199505183322008","article-title":"The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation","volume":"332","author":"Chrousos","year":"1995","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.bbi.2011.01.011_b0085","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neulet.2008.06.007","article-title":"Induction of indolamine 2,3-dioxygenase and kynurenine 3-monooxygenase in rat brain following a systemic inflammatory challenge: a role for IFN-gamma?","volume":"441","author":"Connor","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbi.2011.01.011_b0090","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1749-6632.2001.tb05827.x","article-title":"Cytokine-induced sickness behavior: mechanisms and implications","volume":"933","author":"Dantzer","year":"2001","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.bbi.2011.01.011_b0095","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ejphar.2004.07.040","article-title":"Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity","volume":"500","author":"Dantzer","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbi.2011.01.011_b0100","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bbi.2006.09.006","article-title":"Twenty years of research on cytokine-induced sickness behavior","volume":"21","author":"Dantzer","year":"2007","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2011.01.011_b0105","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: when the immune system subjugates the brain","volume":"9","author":"Dantzer","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbi.2011.01.011_b0110","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0889-1591(02)00005-3","article-title":"Questions raised by the cytokine hypothesis of depression","volume":"16","author":"de Beaurepaire","year":"2002","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2011.01.011_b0115","doi-asserted-by":"crossref","unstructured":"de Beaurepaire, R., Swiergiel, A.H., Dunn, A.J., 2005. Neuroimmune mediators: are cytokines mediators of depression? In: Licinio, J., Wong, M.-L. (Eds.), Biology of Depression, vol. 2. Wiley, Weinheim, pp. 557\u2013581.","DOI":"10.1002\/9783527619672.ch22"},{"key":"10.1016\/j.bbi.2011.01.011_b0120","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrn1683","article-title":"Stress and the brain: from adaptation to disease","volume":"6","author":"De Kloet","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbi.2011.01.011_b0125","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.neubiorev.2005.03.016","article-title":"Endotoxin- or pro-inflammatory cytokine-induced sickness behavior as an animal model of depression: focus on anhedonia","volume":"29","author":"De La Garza","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbi.2011.01.011_b0130","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.pbb.2005.04.019","article-title":"Effects of interleukin-1 and endotoxin in the forced swim and tail suspension tests in mice","volume":"81","author":"Dunn","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbi.2011.01.011_b0135","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.neubiorev.2005.03.023","article-title":"Cytokines as mediators of depression: what can we learn from animal studies?","volume":"29","author":"Dunn","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbi.2011.01.011_b0140","doi-asserted-by":"crossref","first-page":"6227","DOI":"10.1073\/pnas.1034823100","article-title":"Behavioral, neurochemical, and electrophysiological characterization of a genetic mouse model of depression","volume":"100","author":"El","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbi.2011.01.011_b0145","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0091-3057(02)01024-9","article-title":"Sex differences in the effects of muramyl dipeptide and lipopolysaccharide on locomotor activity and the development of behavioural tolerance in rats","volume":"74","author":"Engeland","year":"2003","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbi.2011.01.011_b0150","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.psyneuen.2005.11.007","article-title":"Influence of the estrous cycle on tolerance development to LPS-induced sickness behaviors in rats","volume":"31","author":"Engeland","year":"2006","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bbi.2011.01.011_b0155","first-page":"76","article-title":"Effect of glucocorticoid receptor (GR) blockade on endotoxemia in rats","volume":"42","author":"Fan","year":"1994","journal-title":"Circ. Shock"},{"key":"10.1016\/j.bbi.2011.01.011_b0160","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0022-3956(03)00100-6","article-title":"Neuropsychological correlates of psychotic features in major depressive disorders: a review and meta-analysis","volume":"38","author":"Fleming","year":"2004","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.bbi.2011.01.011_b0165","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/sj.npp.1300884","article-title":"Clinical and biological effects of mifepristone treatment for psychotic depression","volume":"31","author":"Flores","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbi.2011.01.011_b0170","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.psyneuen.2007.03.005","article-title":"Lipopolysaccharide induces delayed FosB\/DeltaFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior","volume":"32","author":"Frenois","year":"2007","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bbi.2011.01.011_b0175","first-page":"CD005168","article-title":"Antiglucocorticoid treatments for mood disorders","volume":"1","author":"Gallagher","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bbi.2011.01.011_b0180","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/15622970310029904","article-title":"Hepatitis C, alpha interferon, anxiety and depression disorders: a prospective study of 71 patients","volume":"4","author":"Gohier","year":"2003","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2011.01.011_b0185","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1176\/appi.ajp.161.6.996","article-title":"Neuropsychological dysfunction in antipsychotic-naive first-episode unipolar psychotic depression","volume":"161","author":"Hill","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbi.2011.01.011_b0190","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0022-3956(98)90056-5","article-title":"The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety","volume":"33","author":"Holsboer","year":"1999","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.bbi.2011.01.011_b0195","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0893-133X(00)00159-7","article-title":"The corticosteroid receptor hypothesis of depression","volume":"23","author":"Holsboer","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbi.2011.01.011_b0200","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ejphar.2007.12.032","article-title":"Central CRH system in depression and anxiety \u2013 evidence from clinical studies with CRH1 receptor antagonists","volume":"583","author":"Holsboer","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbi.2011.01.011_b0205","doi-asserted-by":"crossref","first-page":"R133","DOI":"10.1152\/ajpregu.90335.2008","article-title":"Immune-to-brain signaling and central prostaglandin E2 synthesis in fasted rats with altered lipopolysaccharide-induced fever","volume":"295","author":"Inoue","year":"2008","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.bbi.2011.01.011_b0210","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.bbi.2007.01.010","article-title":"Depressive disorders and immunity: 20 years of progress and discovery","volume":"21","author":"Irwin","year":"2007","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2011.01.011_b0215","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1192\/bjp.155.4.468","article-title":"Consistent reduction of ACTH responses to stimulation with CRH, vasopressin and hypoglycaemia in patients with major depression","volume":"155","author":"Kathol","year":"1989","journal-title":"Br. J. Psychiatry J. Ment. Sci."},{"key":"10.1016\/j.bbi.2011.01.011_b0220","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/0165-6147(92)90012-U","article-title":"Sickness behavior as a new target for drug development","volume":"13","author":"Kent","year":"1992","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbi.2011.01.011_b0225","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0166-2236(00)02088-9","article-title":"Cytokine-induced sickness behaviour: mechanisms and implications","volume":"25","author":"Konsman","year":"2002","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbi.2011.01.011_b0230","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0278-5846(94)00101-M","article-title":"Evidence for an immune response in major depression: a review and hypothesis","volume":"19","author":"Maes","year":"1995","journal-title":"Prog. Neuropsychopharmacol."},{"key":"10.1016\/j.bbi.2011.01.011_b0235","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0193-953X(05)70015-0","article-title":"Neuroendocrine and immune system interactions in stress and depression","volume":"21","author":"Miller","year":"1998","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.bbi.2011.01.011_b0240","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","article-title":"Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression","volume":"65","author":"Miller","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2011.01.011_b0245","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.bbi.2008.04.001","article-title":"Inoculation of bacillus Calmette\u2013Guerin to mice induces an acute episode of sickness behavior followed by chronic depressive-like behavior","volume":"22","author":"Moreau","year":"2008","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2011.01.011_b0250","first-page":"11","article-title":"Involvement and role of antidepressant drugs of the hypothalamic\u2013pituitary\u2013adrenal axis and glucocorticoid receptor function","volume":"30","author":"Nikisch","year":"2009","journal-title":"Neuroendocrinol. Lett."},{"key":"10.1016\/j.bbi.2011.01.011_b0255","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/sj.mp.4002148","article-title":"Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice","volume":"14","author":"O\u2019Connor","year":"2009","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.bbi.2011.01.011_b0260","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1523\/JNEUROSCI.5032-08.2009","article-title":"Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette\u2013Guerin","volume":"29","author":"O\u2019Connor","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2011.01.011_b0265","first-page":"1041","article-title":"Animal research on immunity activation-induced depressive-like behavior: doses and time effects","volume":"39","author":"Pan","year":"2007","journal-title":"Acta Psychologica Sinica"},{"key":"10.1016\/j.bbi.2011.01.011_b0270","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/10253890500069650","article-title":"Glucocorticoid receptor function in vitro in patients with major depression","volume":"7","author":"Pariante","year":"2004","journal-title":"Stress"},{"key":"10.1016\/j.bbi.2011.01.011_b0275","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1749-6632.2009.04978.x","article-title":"Risk factors for development of depression and psychosis. Glucocorticoid receptors and pituitary implications for treatment with antidepressant and glucocorticoids","volume":"1179","author":"Pariante","year":"2009","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.bbi.2011.01.011_b0280","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0006-3223(00)01088-X","article-title":"Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment","volume":"49","author":"Pariante","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2011.01.011_b0285","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0014-2999(03)01272-X","article-title":"The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review","volume":"463","author":"Prut","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbi.2011.01.011_b0290","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0924-977X(00)80088-7","article-title":"Glucocorticoids & cognition in depression","volume":"10","author":"Schatzberg","year":"2000","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.bbi.2011.01.011_b0295","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.pnpbp.2004.11.003","article-title":"Cytokines and major depression","volume":"29","author":"Schiepers","year":"2005","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2011.01.011_b0300","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0024-3205(99)00430-0","article-title":"Differential effect of chronic antidepressant treatments on lipopolysaccharide-induced depressive-like behavioural symptoms in the rat","volume":"65","author":"Shen","year":"1999","journal-title":"Life Sci."},{"key":"10.1016\/j.bbi.2011.01.011_b0305","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/0306-9877(91)90272-Z","article-title":"The macrophage theory of depression","volume":"35","author":"Smith","year":"1991","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.bbi.2011.01.011_b0310","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.bbi.2011.01.011_b0315","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.intimp.2004.04.007","article-title":"Lipopolysaccharide-induced paw edema model for detection of cytokine modulating anti-inflammatory agents","volume":"4","author":"Vajja","year":"2004","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbi.2011.01.011_b0320","first-page":"39","article-title":"Mood and cognitive side effects of interferon-alpha therapy","volume":"25","author":"Valentine","year":"1998","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.bbi.2011.01.011_b0325","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.vascn.2007.02.001","article-title":"A rat pharmacokinetic\/pharmacodynamic model for assessment of lipopolysaccharide-induced tumor necrosis factor-alpha production","volume":"56","author":"Wang","year":"2007","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.bbi.2011.01.011_b0330","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.bbi.2009.06.152","article-title":"LPS-induced indoleamine 2,3-dioxygenase is regulated in an interferon-gamma-independent manner by a JNK signaling pathway in primary murine microglia","volume":"24","author":"Wang","year":"2010","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2011.01.011_b0335","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.psyneuen.2010.01.011","article-title":"Mifepristone decreases depression-like behavior and modulates neuroendocrine and central hypothalamic\u2013pituitary\u2013adrenocortical axis responsiveness to stress","volume":"35","author":"Wulsin","year":"2010","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bbi.2011.01.011_b0340","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0006-8993(95)01415-2","article-title":"Endotoxin produces a depressive-like episode in rats","volume":"711","author":"Yirmiya","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.bbi.2011.01.011_b0345","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1136\/ewjm.173.5.333","article-title":"Depression in medical illness: the role of the immune system","volume":"173","author":"Yirmiya","year":"2000","journal-title":"West J. Med."},{"key":"10.1016\/j.bbi.2011.01.011_b0350","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/978-0-585-37970-8_16","article-title":"Cytokines, \u201cdepression due to a general medical condition\u201d, and antidepressant drugs","volume":"461","author":"Yirmiya","year":"1999","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bbi.2011.01.011_b0355","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1038\/sj.npp.1300471","article-title":"Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder","volume":"29","author":"Young","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbi.2011.01.011_b0360","article-title":"Glucocorticoids, cytokines and brain abnormalities in depression","author":"Zunszain","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088915911100016X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088915911100016X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:26:00Z","timestamp":1760167560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088915911100016X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":72,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S088915911100016X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2011.01.011","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic blockade of glucocorticoid receptors by RU486 enhances lipopolysaccharide-induced depressive-like behaviour and cytokine production in rats","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2011.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}